1429636-56-5

Basic information

• Product Name: [6,7-bis(2-methoxyethoxy)-4-chinazolinyl](3-ethynylphenyl)amine L-pyroglutamate
• CAS NO: 1429636-56-5
• Molecular Weight: 522.558
• Mol File: 1429636-56-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [6,7-bis(2-methoxyethoxy)-4-chinazolinyl](3-ethynylphenyl)amine L-pyroglutamate(CAS DataBase Reference)
• NIST Chemistry Reference: [6,7-bis(2-methoxyethoxy)-4-chinazolinyl](3-ethynylphenyl)amine L-pyroglutamate(1429636-56-5)
• EPA Substance Registry System: [6,7-bis(2-methoxyethoxy)-4-chinazolinyl](3-ethynylphenyl)amine L-pyroglutamate(1429636-56-5)

Safety Data

• Hazardous Substances Data: 1429636-56-5(Hazardous Substances Data)

Upstream product

• 98-79-3 L-Pyroglutamic acid 
• 183321-74-6 erlotinib 

Relevant articles and documents

ERLOTINIB SALTS

The invention relates to erlotinib salts selected from the group consisting of the maleic acid salt, salicylic acid salt. L-mandelic acid alt. adipinic acid salt. 1.5-naphthalene-disulfonic acid salt. L-pyroglutamic acid salt. 1 -hydroxy-2-naphthoic acid salt, and mandelic acid salt and amorphous and crystalline forms, hydrates and solvates thereof. The erlotinib salts of the present invention are useful in therapy, particularly for the treatment or prophylaxis of non- small cell lung carcinoma and pancreas rarcinoma.